Literature DB >> 22130836

Immunocytochemistry to study myogenesis in zebrafish.

Nathan C Bird1, Stefanie E Windner, Stephen H Devoto.   

Abstract

During myogenesis, cells gradually transition from mesodermal precursors to myoblasts, myocytes, and then to muscle fibers. The molecular characterization of this process requires the ability to identify each of these cell types and the factors that regulate the transitions between them. The most versatile technique for assaying cell identities in situ is immunocytochemistry, because multiple independent molecular markers of differentiation can be assayed simultaneously. The zebrafish has developed into a popular model for the study of myogenesis, and immunocytochemical techniques have been critical. We have adapted existing protocols to optimize immunocytochemistry in zebrafish, and have tested many antibodies developed against mouse, chick, and frog muscle antigens for their cross-reactivity in zebrafish. Here, we present protocols for whole mount immunocytochemistry on both formaldehyde and Carnoy's fixed embryos as well as on sectioned zebrafish tissue. We include a table of antibodies useful for experiments on the molecular biology of myogenesis in zebrafish.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22130836     DOI: 10.1007/978-1-61779-343-1_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Cell fusion is differentially regulated in zebrafish post-embryonic slow and fast muscle.

Authors:  Kimberly J Hromowyk; Jared C Talbot; Brit L Martin; Paul M L Janssen; Sharon L Amacher
Journal:  Dev Biol       Date:  2020-03-10       Impact factor: 3.582

2.  Mutations in MYLPF Cause a Novel Segmental Amyoplasia that Manifests as Distal Arthrogryposis.

Authors:  Jessica X Chong; Jared C Talbot; Emily M Teets; Samantha Previs; Brit L Martin; Kathryn M Shively; Colby T Marvin; Arthur S Aylsworth; Reem Saadeh-Haddad; Ulrich A Schatz; Francesca Inzana; Tawfeg Ben-Omran; Fatima Almusafri; Mariam Al-Mulla; Kati J Buckingham; Tamar Harel; Hagar Mor-Shaked; Periyasamy Radhakrishnan; Katta M Girisha; Shalini S Nayak; Anju Shukla; Klaus Dieterich; Julien Faure; John Rendu; Yline Capri; Xenia Latypova; Deborah A Nickerson; David M Warshaw; Paul M L Janssen; Sharon L Amacher; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2020-07-23       Impact factor: 11.025

3.  Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage.

Authors:  Abraham P Fong; Zizhen Yao; Jun Wen Zhong; Nathan M Johnson; Gist H Farr; Lisa Maves; Stephen J Tapscott
Journal:  Cell Rep       Date:  2015-03-19       Impact factor: 9.423

4.  The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy.

Authors:  Nathan M Johnson; Gist H Farr; Lisa Maves
Journal:  PLoS Curr       Date:  2013-09-17

5.  Cited3 activates Mef2c to control muscle cell differentiation and survival.

Authors:  Gnanapackiam Sheela Devakanmalai; Hasan E Zumrut; Ertuğrul M Ozbudak
Journal:  Biol Open       Date:  2013-04-11       Impact factor: 2.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.